2017
DOI: 10.1002/slct.201701153
|View full text |Cite
|
Sign up to set email alerts
|

Peptide‐Conjugated Nano‐Drug Delivery System to Improve Synergistic Molecular Chemotherapy for Colon Carcinoma

Abstract: The biofunctional significance of hollow mesoporous silica nanoparticles (HMSNs) could be used as nano-reservoirs. Here in the b-sitosterol loaded into the hollow core and the cisplatin substituted with the carboxylic group of poly lactic acid (PLA)polyethylene glycol (PEG) on the pore walls of HMSNs. Subsequently, the tumour biomarker somatostatin peptide (3207-86) conjugated to Methyl polyethylene glycol 2-maleimide ethyl ether (Meo-PEG-Mal) for the selective targeting of tumour cells. The surface modified H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 49 publications
0
4
0
Order By: Relevance
“…This could elucidate the possible interaction of the nanomaterial with endolysosome membranes because of transitory undermining of the cell membranes, resulting in the easy entry of the nanomaterial into the cytosol. 40 , 41 At this stage, the BBR is released from FA-PEG@BBR-AgNPs, after the accretion of the nanomaterial in MDA-MB-231 cells. The aim of the study is to assess the MDA-MB-231 cell-targeting capability of the nanocarrier such as BBR-AgNPs and FA-PEG@BBR-AgNPs through FA receptor-binding efficacy (over-expressed in many types of cancer).…”
Section: Resultsmentioning
confidence: 99%
“…This could elucidate the possible interaction of the nanomaterial with endolysosome membranes because of transitory undermining of the cell membranes, resulting in the easy entry of the nanomaterial into the cytosol. 40 , 41 At this stage, the BBR is released from FA-PEG@BBR-AgNPs, after the accretion of the nanomaterial in MDA-MB-231 cells. The aim of the study is to assess the MDA-MB-231 cell-targeting capability of the nanocarrier such as BBR-AgNPs and FA-PEG@BBR-AgNPs through FA receptor-binding efficacy (over-expressed in many types of cancer).…”
Section: Resultsmentioning
confidence: 99%
“…Human MDA-MB-231 breast cancer cells were collected from the National Center for Cell Science, Pune, India and stored in DMEM media enriched with 10% FBS, 1% Lglutamine, 1% penicillin, and 1% streptomycin stock solution, at 37°C and 5% CO 2 . The medium was modified every two days and the cells were transferred by trypsinization prior to confluence [30][31][32].…”
Section: Cell Lines and Cell Culturementioning
confidence: 99%
“…As a result, nanomedicine has garnered considerable interest in the scientific community as a promising avenue for diagnosing, treating, and preventing immune and tumor diseases. [ 2,3 ]…”
Section: Introductionmentioning
confidence: 99%